Seiro Satohisa
Sapporo, 0608543, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
ERα increases endometrial cancer cell resistance to cisplatin via upregulation of BAG3.
Journal: Oncology letters
Published: June 15, 2020
ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer.
Journal: Histochemistry and cell biology
Published: March 29, 2020
Possibility of Targeting Claudin-2 in Therapy for Human Endometrioid Endometrial Carcinoma.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: February 18, 2020
Epithelial barrier dysfunction and cell migration induction via JNK/cofilin/actin by angubindin-1.
Journal: Tissue barriers
Published: November 30, 2019
Localization of Tricellular Tight Junction Molecule LSR at Midbody and Centrosome During Cytokinesis in Human Epithelial Cells.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: October 31, 2019
Efficacy of liquid-based genetic diagnosis of endometrial cancer.
Journal: Cancer science
Published: August 17, 2018
Rap1GAP inhibits tumor progression in endometrial cancer.
Journal: Biochemical and biophysical research communications
Published: January 29, 2017
Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer.
Journal: Scientific reports
Published: June 20, 2016
Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer.
Journal: Oncology letters
Published: February 09, 2016
BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer.
Journal: International journal of oncology
Published: January 21, 2016
The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells.
Journal: Oncotarget
Published: January 15, 2016
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial.
Journal: The journal of obstetrics and gynaecology research
Published: February 25, 2015
Last Updated: 09/26/2026